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Abstract Metabolites from Lactobacillus acidophilus
were analysed. The results showed that Lactobacillus
acidophilus Ind-1 and Lactobacillus acidophilus Lakcid
produced respectively 12.73 g and 13.33 g lactic acid l–1
after incubating in skim milk at 37 C for 36 h; and
2.229 unit and 1.808 unit b-galactosidase l–1 in an MRS
medium. The proteolytic activity of Lactobacillus
acidophilus was high and the content of 17 free amino
acids in the fermented milk of Lactobacillus acidoph-
ilus Ind-1 and Lactobacillus acidophilus Lakcid was
394.4 mg l–1 and 563.2 mg l–1, respectively. Meantime,
Lactobacillus acidophilus reduced cholesterol level in
an MRS medium supplemented with cholesterol.
Furthermore, Lactobacillus acidophilus Ind-1 and
Lactobacillus acidophilus Lakcid showed antimicrobial
activity against Bacillus anthracis and Escherichia coli.
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Introduction
Lactobacillus acidophilus is one of the major species of
the natural microflora in animal and human intestines.
Lactobacilli, in sufficient quantity, can create special
probiotic effects: (1) act as barriers against pathogenic
organisms; (2) assist in lactose digestion; (3) improve he
nutritional level of food products; (4) potentially
enhance the development of host’s immune response;
and (5) reduce cholesterol level (Fuller 1991; Gilliland
1990a). Thus, dairy products containing Lactobacillus
acidophilus have an increased value as a dietary sup-
plement (Zhao et al. 2001, 2005). Generally, the ideal
probiotic microorganism would be one which could go
through gastrointestinal environment and establish
itself permanently in the intestine. When present in a
food product, clinical evidence for any stated health
effect and laboratory verification of important param-
eters for physiological function should be considered.
Some clinical trials have shown promising potentials
that Lactobacillus can be used to treat disorders asso-
ciated with intestinal disturbances due to pathogens
(Clements et al. 1981, 1983). Oksanen et al. (1990)
treated with lactobacilli 756 Finnish tourists who trav-
eled to Turkey and suffered from diarrhea. He ob-
served a decrease in diarrhea frequency from 71% to
43% by the treatment with lactobacilli. Suarez and
Savaiano (1997) reported that fermented milk, espe-
cially yogurt greatly improves lactose digestion for
persons with a low intestinal lactase activity, due to the
existence of the bacterial enzyme b-galactosidase. This
explained why these individuals could tolerate yogurt
very well while they developed symptoms of lactose-
intolerance after ingesting similar amounts of milk.
Others reported the enhancement of host immune
response in experimental animals like mice (Perdigon
1989) and reduction of the cholesterol level in pigs (Lin
1989). However, the physiological significance of these
tests for humans and evidence supporting these claims
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have not yet been thoroughly established. Yogurt is
very popular because of its pleasant flavor and special
nutritional properties. However, yogurt starters used
nowadays are dominantly Lactobacillus delbrueckii
subsp. bulgaricus and Streptococcus thermophilus.
These bacteria produce lactic acid, acetic acid, bacte-
riocins, and others, but cannot survive in the gastro-
enteric environment and colonize the intestines to
promote human health. According to the literature, a
minimum concentration of Lactobacillus acidophilus,
105 c.f.u. (colony-forming units) to 106 c.f.u. per ml, or
per gram product is needed to have therapeutic benefits
(Kurmann and Rasic 1988). Nevertheless, evidence
supporting probiotic claims of Lactobacillus acidophi-
lus is very slight. This means that more study of the
probiotic characteristics of Lactobacillus acidophilus is
needed to give an explanation for the positive effect on
human and animal health. In this study we aimed at: (1)
examining some metabolites produced by Lactobacillus
acidophilus (such as lactic acid, b-galactosidase, 17 free
amino acids); (2) testing cholesterol reduction and
antimicrobial activity on pathogenic organisms.
Materials and methods
Microorganisms
Lactobacillus acidophilus Ind-1 (La-1) and Lactoba-
cillus acidophilus Lakcid (La-2) were obtained from
the Department of Food Science, Henan Institute of
Science and Technology. Bacillus anthracis and
Escherichia coli were obtained from Sanitation and
Anti-epidemic Station of Xinxiang City, Henan Prov-
ince, China.
Media
La-1 and La-2 were incubated in skim milk at 37 C for
36 h to measure the concentration of lactic acid and
free amino acids, and incubated in deMan Rogosa and
Sharpe (MRS) medium supplemented with 4%(w/v)
lactose as described by Zhao et al. (2003) to determine
b-galactosidase, and with different content cholesterol
to test cholesterol reduction. Bacillus anthracis and
Escherichia coli were grown on nutrient culture med-
ium (peptone 5.0 g, meat concentrate 3.0 g, yeast
extract 1.0 g, agar 10.0 g, in 1000 ml water, pH 6.8).
Assay for lactic acid
Sterilized skim milk was inoculated with 10% (v/v)
liquid culture of La-1 and La-2 aseptically, and then
incubated at 37 C for 36 h. The fermented skim milk
was extracted with 80% (v/v) ethanol, at 75 C for
15 min and centrifuged (RC-5C, Low Temperature
Superspeed Centrifuge, America Sorvall@ instruments
Du Pont Company) at 1,247 g for 15 min, followed by
the collection of the supernatant. The supernatant was
centrifuged again at 31,186 g for 15 min, followed by
ultrafiltration (0.45 lm). The ultrafiltrate (10 ll) was
assayed by HPLC at 275 nm (2996PDA Detector,
Waters Empower HPLC System, Waters Co. U.S.A).
The injected doses of standard samples of lactic acid,
oxalic acid, citric acid, tartaric acid, malic acid, acetic
acid and succinic acid were 0.200, 0.005, 0.120, 0.005,
0.150, 0.200, 0.180 g l–1, respectively, according to the
sensibility of forming the wave front. By comparing
with the standard time of the forming peak,
and according to the relative peak area, the amount
of every organic acid above was calculated (Ning
2001).
Assay for b-galactosidase
Lactose can be decomposed into one glucose and one
galactose and is used as substrate for b-galactosidase
determination. The structure of the colourless O-
nitrophenyl-b-D-galactopyranoside (ONPG) is similar
to that of lactose, and also can be decomposed by
b-galactosidase into yellowish O-nitrophenol (ONP).
The amount of ONP released can be measured to
determine b-galactosidase activity by spectrophotom-
eter (Qian 1992). To collect cells, 50 ml of MRS
culture was centrifuged at 3,600 g for 15 min. The
precipitate was washed twice with 0.05 M NaH2PO4
buffer, and 10 ml NaH2PO4 buffer was added to
make the cell suspension thereafter. Then 100 ll
solvent mixture (1%SDS(w/v):chloroform = 1:10, by
vol. ) was added and incubated at 37 C for 30 min,
and followed by centrifugation (4,000 g, 10 min). The
supernatant (1 ml) mixed with 4 ml 0.005 M ONPG
was incubated at 37 C for 20 min. The reaction was
stopped by adding 5 ml 0.5 M cold Na2CO3. The
amount of ONP released was measured by spectro-
photometry at 420 nm (U/V-1100 u.v. spectropho-
tometer, Beijing Ruili Analytic Facility Company,
Beijing, China). The units of lactase activity utilizing
ONPG as substrate was expressed as the formation of
micromole (lmol) of ONP from ONPG per min per
liter sample. That is, 1 unit l–1 b-galactosidase equal-
led to 1 lmol ONP from ONPG per min per liter
sample, relatively (Qian 1992). The growth curves of
La-1 and La-2 were followed by measuring the opti-
cal density (O.D.) at 600 nm in MRS (Braun et al.
1981).
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Assay for free amino acid
About 5 ml of fermented skim milk (the same method
as for lactic acid described above) mixed with 10 ml
10% (v/v) metaphosphate, was centrifuged at 17,542 g
for 15 min. Subsequently, 1 ml supernatant was mixed
with 1 ml of citric acid buffer (pH 2.2). The mixture
(50 ll) was collected and 17 free amino acids were
quantitatively determined by an Amino Acid Analytic
Facility (121MB, America Beckman Company) (Zhao
et al. 2002; Ning 2001).
Test of cholesterol reduction
The normal human serum cholesterol level is between
2.33 mmol–1 and 5.69 mmol–1 (the criteria normally
used to judge hypercholesteremia), MRS medium was
supplemented with cholesterol to reach 7.755 mmol–1,
5.170 mmol–1 and 2.585 mmol–1, respectively, then
sterilized at 121 C for 15 min, cooled to 37 C,
inoculated with liquid culture (10%, v/v), and incu-
bated at 37 C for 24 h. Culture broth (1.5 ml) was
centrifuged at 900 g for 10 min, and 0.5 ml superna-
tant was added with 3.0 ml color reagent, containing
0.03 ml cholesterol oxidase (20 unitml–1), 8 mg
cholesterol esterase (40 unitg–1) and 0.1 mg peroxi-
dase (Reinheit Zahl = 3 mg–1), and kept at 37 C in a
water bath for 10 min. The amount of cholesterol was
determined by the so-called CHOD-PAP method
with spectrophotometer at 500 nm (Gilliland and
Walker 1990b; Ning 2001). The experiments were
done in duplicate and the control was done without
adding liquid culture.
Antimicrobial activity against B. anthracis
and E. coli
Bacillus anthracis and E. coli were inoculated by plate
spreading under aseptic conditions on nutrient culture
medium plates, cultivated at 37 C for 1 h to make the
colony fixed, then 3 discs with a diameter of 3 mm in
each plate were stabbed and 3 holes remained. MRS
liquid medium previously inoculated by 10% (v/v) La-1
and La-2 was incubated at 37 C for 36 h to make the
liquid culture reach 106 c.f.u. ml–1 La-1 and La-2, after
which it was injected into the 3 holes. After 24 h
incubation at 37 C, antimicrobial activity was mea-
sured by agar diffusion method as modified by Kirby-
Bauer, recommended by World Health Organization
(WHO) in 1997 (Ling and Dong 1999; Li et al. 2003;
Mo et al. 2005).
Results and discussion
Organic acid produced by Lactobacillus acidophilus
Levels and kinds of accumulated organic acids by La-1
and La-2 were shown in Table 1. The amount of lactic
acid of La-1 and La-2 was 12.73 g l–1 and 13.33 g l–1,
oxalic acid was 0.70 g l–1 and 0.45 g l–1, and citric acid
was 1.02 g l–1 and 0.75 g l–1, respectively. Trace
amounts of malic acid were produced, while no tartaric
acid, acetic acid and succinic acid were detected.
According to the amount of lactic acid, carbohydrate
fermentation of Lactobacillus acidophilus in skim milk
was homolactic, with lactic acid being more than 90%
of the end products. This meant that the test strains
could increase lactose utilization and hence lower lac-
tose concentration in milk. This was probably one of the
reasons why Lactobacillus acidophilus strains were able
to increase lactose tolerance for individuals, and con-
sequently, they could be used in probiotic preparations.
b-galactosidase activity in MRS
Experiments had revealed that b-galactosidase could
improve lactose utilization for lactose-intolerant
persons (Jiang et al. 1996). Lactose is taken up by a
specific permease inside bacterial cells and is split by
b-galactosidase into glucose and D-galactose (Kandler
1983). Figure 1 gives the levels of b-galactosidase
activity and the relationships between the microbial
growth and the production of b-galactosidase by La-1
and La-2 at certain incubation times. Compared with
the growth curves of La-1 and La-2 (Fig. 1), the change
of b-galactosidase activity had a different trend. The
enzyme activity of La-1 and La-2 increased with the
cultivation time and reached its peak of 2.229 unit l–1
and 1.808 unit l–1 at 36 h, respectively. After 36 h,
levels of b-galactosidase activity declined and at 60 h
had fallen to 1.387 unit l–1 and 0.922 unit l–1, respec-
tively for La-1 and La-2. Reportedly, other strains used
Table 1 Types and quantity of organic acid formed by
Lactobacillus acidophilus
Organic acid Quantity (g/l)
La-1 La-2
Oxalic acid 0.70 0.45
Tartaric acid n.d.a n.d.
Malic acid trace trace
Lactic acid 12.73 13.33
Acetic acid n.d. n.d.
Citric acid 1.02 0.75
Succinic acid n.d. n.d.
an.d. = not detected
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in fermented milk such as Lactococcus lactis subsp.
lactis E only produced 0.146 unit b-galactosidase l–1
and Lactococcus lactis subsp. lactis C10 produced 0.331
unit b-galactosidase l–1 (Pochart et al. 1989). In our
study, La-1 and La-2 had much higher b-galactosidase
activity than that of above reported strains. This con-
firmed again why Lactobacillus acidophilus strains
were able to improve lactose tolerance for individuals.
Production of free amino acids in fermented skim
milk
Through fermentation, the amount of amino acids in
skim milk increased greatly compared with unfermented
skim milk (as shown in Fig. 2), especially glutamic acid,
proline, asparagine, valine, leucine, tyrosine and argi-
nine. The total amount of amino acids of fermented skim
milk by La-1 and La-2 was 394.4 mg l–1 and 563.2 mg l–1,
respectively. Unfermented milk had only 43.2 mg l–1
and yogurt fermented by a routine starter culture with a
mixture of Lactobacillus delbrueckii subsp. bulgaricus
and Streptococcus thermophilus had 151.1 mg free
amino acids l–1. In our study, La-1 and La-2 indeed had
the ability to hydrolyze milk proteins to free amino acids.
This also indicated that different strains showed differ-
ent abilities to hydrolyze milk protein. As protein
availability in milk was evaluated by its free amino acid
content, fermentation by La-1 and La-2 improved the
quality and availability of milk protein.
Assay for cholesterol reduction
Figure 3 (a and b) show the cholesterol reduction
ability of La-1 and La-2 in MRS medium supplemented
0
0.5
1
1.5
2
2.5
0 12 24 36 48 60
Time(h)
β-g
al
ac
to
sid
as
e 
(un
it/l
)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
O
pt
ic
al
 d
en
sit
y 
(60
0n
m)
β-galactosidase activity of La-1 β-galactosidase activity of La-2
growth curve of La-1 growth curve of La-2
Fig. 1 Growth and b-galactosidase production by Lactobacillus
acidophilus
0
20
40
60
80
100
120
140
160
180
Asp Thr Ser Glu Pro Gly Ala Cys Val Met Ile Leu Tyr Phe Lys His Arg
Amino acid
m
g/
l
La-1 La-2 freshmilk (Control 1) general yogurt (Control 2)
Fig. 2 Content of free amino
acid in fermented milk of
La-1 and La-2
0
1
2
3
4
5
6
7
8
9
0 12 15 18 21 24
Time(h)
Ch
ol
es
te
ro
lle
ve
(m
mo
l/l)
7.755mmol/l 5.170mmol/l 2.585mmol/l
0 12 15 18 21 24
Time(h)
0
1
2
3
4
5
6
7
8
9
Ch
ol
es
te
ro
lle
ve
(m
mo
l/l)
7.755mmol/l 5.170mmol/l 2.585mmol/l
a
b
Fig. 3 (a) The cholesterol reduction ability of La-1 (b) The
cholesterol reduction ability of La-2
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with different cholesterol level, namely 7.755 mmol l–1,
5.170 mmol l–1 and 2.585 mmol l–1, respectively.
Figures 3a and b show that La-1 and La-2 could
reduce cholesterol level if the initiation concentration
was 7.755 mmol–1 and 5.170 mmol–1 in MRS medium,
no effect on that of 2.585 mmol–1. From Figure 3, we
also could see that the reduction of cholesterol level
was mainly made within 12 h at the beginning, and
with the time on, the changes were very small. After
24 h, the cholesterol levels were all below the critical
level 5.69 mmol–1, a critical point above which one will
be judged to have hypercholesteremia. There was no
any change in control test. This implies that Lactoba-
cillus acidophilus was effective in reducing cholesterol
level in MRS medium. However, these were only in
vitro. Further tests on animals or humans should be
done to prove whether Lactobacillus acidophilus could
really reduce serum cholesterol level.
Antimicrobial effects on pathogenic bacteria
As shown in Figs. 4a and b, the zones of growth inhi-
bition on B. anthracis and E. coli by La-1 were
16–18 mm and 16–20 mm, and by La-2 were 20–22 mm
and 18–20 mm, respectively. This meant that La-1 and
La-2 had antimicrobial effect against B. anthracis and
E. coli. They could act as an antibacterial agent against
certain Gram-positive and -negative pathogenic bac-
teria. The mechanism of the antimicrobial effect was
very complicated. These activities might have been
resulted from some organic acids, or from other
metabolites, such as bacteriocin, analogous bacteriocin
and H2O2, etc. (Schilliager et al. 1997), as well as
Bifidobacterium and Lactobacillus acting as probiotic
microorganisms with antagonistic action toward intes-
tinal pathogens (Hotta et al. 1987; Isolauri et al. 1991).
Conclusions
Strains La-1 and La-2 had clear probiotic properties
including acidification, b-galactosidase activity, proteolytic
activity, cholesterol reduction, and antagonistic action
on B. anthracis and E. coli. This confirmed that Lac-
tobacillus acidophilus could be used as a potential
probiotic dietary supplement.
La-1 La-2
La-1 La-2
a
b
Fig. 4 (a) Antibacterial activity of La-1 and La-2 on B. anthracis (b) Antibacterial activity of La-1 and La-2 on E. coli
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